Abstract: A compound capable of functioning as a phosphorescent emitter in an organic light emitting device at room temperature that includes at least one aromatic ring and at least one substituent R where each of the at least one R is of Formula I

Abstract: Provided are organometallic compounds comprising a platinum atom as the central atom which is complexed by a tetradentate ligand comprising at least three rings as well as a at least one bicyclic moiety comprising at least one nitrogen atom. Also provided are formulations comprising these organometallic compounds. Further provided are organic light emitting devices (OLEDs) and related consumer products that utilize these organometallic compounds.

Abstract: The present invention includes a new series of heteroleptic iridium complexes that demonstrate high efficiency in OLED device.

Abstract: A compound having the formula: Formula I is disclosed. The compound is useful as emitters in OLEDs.

Abstract: Provided are organometallic compounds. Also provided are formulations comprising these organometallic compounds. Further provided are OLEDs and related consumer products that utilize these organometallic compounds.

Abstract: A compound comprising a first ligand LA of Formula I, is provided. In Formula I, each of X1 to X12 is C or N; Y is a linking group; each RA, RB and RC can be hydrogen or a substituent; at least one RA, RB or RC comprises an electron-withdrawing group; and LA forms a 5-membered chelate ring with an Ir atom via the dashed lines. In addition a number of conditions must be met based on whether or not any pair of RA is joined to form a ring. Formulations, OLEDs, and consumer products containing the compound are also provided.

Abstract: A compound including a first ligand LA of Formula I is disclosed. The compound is useful as an emitter in phosphorescent OLEDs.

Abstract: Provided are organoiridium compounds that are useful as emitters in OLEDs. The compounds have Formula I L1L2Ir-L-Ir-L3L4, where: L is a bis-bidentate ligand including two or more aromatic rings; one of the two or more aromatic rings is bonded to the two Ir atoms at the same time; and each of L1, L2, L3, and L4 is independently a bidentate N-heterocyclic carbene ligand or a substituted or unsubstituted acetylacetonate ligand with L1, L2, L3, and L4 each being the same or different. Also provided are formulations including these organoiridium compounds. Further provided are OLEDs and related consumer products that utilize these organoiridium compounds.

Abstract: A compound comprising a first ligand LA of Formula I, is provided. In Formula I, moiety A and moiety B either a monocyclic ring or a polycyclic fused ring system; each of X1 to X4, Z1, and Z2 is C or N; K1 is a direct bond, O, S, N(R?), P(R?), B(R?), C(R?)(R?), or Si(R?)(R?); L1 is a direct bond or a linking group; each R?, R?, RA and RB is hydrogen or a General Substituent; and LA is coordinated to a metal M. In addition, RA or RB alone or in combination with a substituent of L1 form a 7-membered ring. Formulations, OLEDs, and consumer products containing the compound are also provided.

Abstract: A compound including a first ligand LA of is disclosed. In the structure of Formula I, one of L1 and L2 is C, and the other is N; Y1 to Y14 are each C or N; at least two adjacent Y7, Y8, Y9, and Y10 are carbon atoms that are fused to a structure of Z1 and Z2 are each O, S, Se, NR, CRR?, or SiRR?; and each R, R?, RA, RB, RC, and RD is hydrogen or a substituent; and any two substituents may be joined or fused together to form a ring. In the compound, LA is complexed to a metal M by L1 and L2, and M has an atomic weight greater than 40. Organic light emitting devices and consumer products containing the compounds are also disclosed.

Abstract: A compound comprising a first ligand LA of Formula I, In Formula I, moiety B is a monocyclic ring or a polycyclic fused ring system; X1, X2, and Z1 are C or N; Y1 is O, S, Se, Te, CRR?, SiRR?, GeRR?, PR, AsR, SbR, or BiR; K1 is a direct bond, O, S, N(R?), P(R?), B(R?), C(R?)(R?), or Si(R?)(R?); each R, R?, R?, R?, RA, and RB is hydrogen or a general substituent; any two substituents may be joined or fused to form a ring; LA is coordinated to a metal M to form a 5-membered or 6-membered chelate ring; and two RB substituents join to form a 5-membered ring if Y1 is O, S, or Se. Formulations, OLEDs, and consumer products comprising the compound are also provided.

Abstract: A compound comprising a ligand of LA of Formula I, is provided with variables as defined herein. Formulations, OLEDs, and consumer products including the compound are also disclosed.

Abstract: Provided are transition metal compounds having 1,2,3-triazine. Also provided are formulations comprising these transition metal compounds having 1,2,3-triazine. Further provided are OLEDs and related consumer products that utilize these transition metal compounds having 1,2,3-triazine.

Abstract: A compound including a first ligand LA selected from the following group: is disclosed.

Abstract: Provided are organometallic compounds comprising iridium as a central metal atom which is coordinated by two three-dentate ligands which each comprise at least three 5-membered or 6-membered rings. Also provided are formulations comprising these organometallic compounds. Further provided are organic light emitting devices (OLEDs) and related consumer products that utilize these organometallic compounds.

Abstract: A compound, Ir(LA)(LB)(LC), having a structure of Formula I, is provided. In Formula I, LA includes moieties E and F, LB includes moieties A and B, and LC includes moieties C and D. In addition, moieties A, B, C, D, E, and F are independently monocyclic rings or polycyclic fused ring systems; each of Z1 to Z6 is C or N; three of Z1 to Z6 form covalent bonds to Ir, while the remaining three form dative bonds to Ir; one of Z2 and Z3 forms a covalent bond to Ir, and the other forms a dative bond to Ir; each of L1, L2, L3, and L4 is a direct bond or an organic linker; and each RA, RB, RC, RD, RE, and RF is hydrogen or a General Substituent.

Abstract: Provided is a compound of Formula Ir(LA)(LB)(LC), wherein LA is a ligand of LB is a ligand of and LC is a ligand of wherein a structure of is fused to the ligand LB of Formula II through two adjacent C of X1-X4.

Abstract: A compound is disclosed that has a metal coordination complex structure having at least two ligands coordinated to the metal; wherein the compound has a first substituent R1 at one of the ligands' periphery; wherein a first distance is defined as the distance between the metal and one of the atoms in R1 where that atom is the farthest away from the metal among the atoms in R1; wherein the first distance is also longer than any other atom-to-metal distance between the metal and any other atoms in the compound; and wherein when a sphere having a radius r is defined whose center is at the metal and the radius r is the smallest radius that will allow the sphere to enclose all atoms in the compound that are not part of R1, the first distance is longer than the radius r by at least 2.9 ?.

Abstract: Novel Pt tetradentate complexes having Pt—O bond is disclosed. These complexes are useful as emitters in phosphorescent OLEDs.

Abstract: Provided are organometallic compounds comprising a platinum atom as the central atom which is complexed by a tetradentate ligand comprising at least three rings as well as a at least one bicyclic moiety comprising at least one nitrogen atom. Also provided are formulations comprising these organometallic compounds. Further provided are organic light emitting devices (OLEDs) and related consumer products that utilize these organometallic compounds.